Icecure Medical is trading up 5.77% at $1.10 on October 16, 2026, with healthcare-sector strength a possible supporting factor. - No new company-specific announcement explaining the move was found. Its October 13 release highlighted ProSense clinical data and physician engagement at EUSOBI 2026, but does not establish a direct cause for this session’s rise. - XLV gained 2.12% during regular trading while broader indexes were lower; trading volume or activity details were not verified.